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Abstract: The ongoing evolution of sepsis as a condition constitutes a global health concern and necessitates continuous monitoring
and investigation of incidence rates, mortality factors, and disease patterns. This study sought to elucidate the frequency of bacterial
cultures in patients with septicemia at our hospital and identify the factors influencing mortality. Zoonotic risk factors with reference
to the literature were also taken into account.Independent variables of all patients diagnosed with sepsis were retrospectively screened
to reveal factors affecting mortality. Incomplete or unclear data were not included. Continuous variables are represented as means and
standard deviations, whereas binary variables are represented as percentages and frequency values. The distribution was evaluated using
the Kolmogorov–Smirnov test. Separately, the Student’s t-test or Mann–Whitney U test was used to compare differences for continuous
variables between independent groups according to distribution status. Dichotomous variables were evaluated using the chi-squared
or Fisher’s exact test. Significant results found during univariate analysis were reevaluated using linear and binary logistic regression.
Neither the length of hospital stay nor patient age was statistically significant, for mortality. Among dichotomous variables, sex also did
not impact the mortality rate. Meanwhile, Salmonella, Shigella, and Pseudomonas aeruginosa infections were found to cause mortality.
During the final statistical analysis using multiple logistic regression, only P. aeruginosa was a factor influencing the mortality rate.
P. aeruginosa is an important pathogen that contributes to increased risks of mortality and zoonotic transmission among patients with
sepsis.
Key words: Septicemia, Pseudomonas aeruginosa, zoonotic transmission, mortality, nosocomial infection

1. Introduction
The significance of the development of antibiotic resistance
is well known and is related to the feasibility of transition
zone creation for various diseases between humans/the
environment, and animals. Although many studies have
presented important evidence that antimicrobial drugresistant bacteria may spread from animals to humans,
some research also suggests that humans can also transmit
resistant pathogens to animals in a reverse zoonotic event
known as zooanthroponosis.
Separately, another significant issue of concern in
the fight against infectious diseases is sepsis, which
significantly increases the risk of mortality. Some clinical
studies have estimated that sepsis occurring in 30%–50% of
hospitalised patients’ results in death [1,2]. Sepsis is a lifethreatening condition that arises when the body’s reaction
to an infection damages its own structures and organs [3,4].
Currently, there is no gold-standard diagnosis for sepsis,
and nonstandard descriptions limit the comparability of
results among clinical and epidemiological studies [4]. It

is thought that cornerstone risk factors for sepsis are those
that are risk factors for zoonotic transition to humans.
While animals in healthcare facilities have traditionally
been limited to laboratories and research fields, their
presence in patient care settings is now more common
in both acute and long-term care settings. Unfortunately,
this can lead to the potential transmission of zoonotic
pathogens from animals to humans in these environments
[5]. Although dogs and cats are common in health centre
locations, other animals such as fish, birds, nonhuman
primates, rabbits, and rodents are also used for research
or as service animals. These animals can be a source of
zoonotic pathogens and may pose a risk to both patients
and health care personnel [5]. Despite advances in hospital
treatment and care, current epidemiological studies show
that sepsis remains a major burden worldwide [6]. Walkey
et al. stated that the frequency of sepsis cases increased
from 359/100,000 to 535/100,000 residents between 2003
and 2009, and this rate increased daily in the United States
[7]. However, according to findings obtained by scanning
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ICD-9 codes, there are also studies in the United States
stating that current hospital sepsis rates are higher than
ICU, and it is stated that it ranges from about 25% to 30%
[8]. Recently, the existing criteria for sepsis have been
revised in an attempt to overcome the nondiscriminatory
limitations between infections and sepsis [8]. In general,
50% of all sepsis cases are caused by Gram-negative rods,
but half of them are correlated with a positive blood culture
[9]. In septic shock, 50% to 60% of cases are the result of
Gram-negative bacteria, while 5% to 10% of cases are caused
by Gram-positive bacteria or circulatory fungal infections
[10]. The prevalence of sepsis is expected to increase in the
future due to the growth in antibiotic-resistant bacteria
and an increase in the use of immunosuppressive therapy,
invasive procedures, and device transplantations. At this
time, sepsis is already the most common cause of death
among patients hospitalised in noncoronary intensive care
units [11]. This study sought to clarify the types of bacteria
isolated from patients with sepsis at a single hospital in
Turkey, determine whether there are any bacterial species
that pose a particularly high zoonotic risk, and outline the
risk factors capable of affecting patient mortality rates.
2. Materials and methods
2.1. Patients and management
Prior to its implementation, the present study received
institutional review board approval (decision no. 90057706799, 27 June 2019). Eligible data for analysis were collected
from 30 May 2015 to 30 May 2019 at Yirmidokuz Mayıs
State Hospital. The records of all patients diagnosed with
sepsis were reviewed retrospectively. Eighty-six infected
patients with white blood cell counts of less than 4000/
mm3 or greater than 12,000/mm3, which are laboratory
markers for sepsis, were diagnosed by the culture method.
Our target population included cases diagnosed as sepsis
whose clinical and laboratory values could be confirmed.
More specifically, we included white blood cell counts
and data on other vitals in cases in which we could access
official, clinical records clearly indicating sepsis. We also
included patients whose culture results were positive per
collected data of vitals such as respiratory rate, pulse rate,
and body temperature per the general definition of sepsis;
the condition involves a detected infectious pathogen
together with systemic inflammatory reaction syndrome
(SIRS) [12]. However, at least two of the following
systemic inflammatory response criteria should be present
when making a diagnosis: (a) a body temperature of below
36 °C or above 38 °C; (b) a heart rate of 90 beats/min, a
respiratory rate of 20 breaths/min or more and a Pa CO2 of
less than 4.3 kPa; (c) a white blood cell count of less than
4000/mm3; and (d) a count of greater than 12,000/mm3
or immature cell 10% (band form) [12]. Patients with no
clinical diagnosis of sepsis or those with a diagnosis code
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for sepsis but whose laboratory values were not compatible
with sepsis were excluded. In other words, if there were
no detected microbiologic pathogens or if the vitals data
or white blood cell count were within normal limits, we
did not consider these as sepsis cases. Among the study
population, the characteristics we aimed to examine as
secondary outcomes were C-reactive protein (CRP) level,
urea, creatinine, hemoglobin, partial thromboplastin time,
prothrombin time, international normalised ratio (INR),
fever, respiratory rate, and heart rate to identify factors
affecting mortality. Incomplete or unclear data were not
included. Age, sex, length of hospital stay, clinical patient
distribution, and microorganisms isolated from patients
with sepsis were analysed separately by considering
demographic patterns.
2.2. Statistical analysis
When evaluating continuous variables, the Student’s
t-test or the Mann–Whitney U test was used to compare
differences between independent groups according
to distribution status, which was determined by the
Kolmogorov–Smirnov test. When evaluating binary
variables, the chi-squared or Fisher’s exact test was
performed. For 95% safety limits, a P-value of less than
0.05 was adopted. According to univariate analysis results,
factors affecting mortality were determined using multiple
linear or binary logistic regression. Statistical analysis
was conducted using the Statistical Package for the Social
Sciences Version 22 software program (IBM Corp.,
Armonk, NY, USA).
3. Results
The average age of the patients was 75.25 ± 16.51 years
old, and there was a significant difference in mean age
between the sexes. Men were diagnosed with sepsis at a
younger age (70.59 ± 18.9 years vs. 79.51 ± 12.68 years; P =
0.013). There was also no statistically significant difference
regarding the length of hospital stay observed between
men and women (28.90 ± 33.29 days vs. 26.31 ± 29.78
days; P = 0.747) (Table 1). While there was no statistically
significant difference in mortality rate according to sex,
patients under general intensive care more often died as a
result of septicemia (Table 1).
When we used the chi-squared test as a univariate test
to compare cases of white blood cell counts of less than
4000 × 109 cells/L to those with more than 12,000 × 109
cells/L, which are important whole blood criteria for the
diagnosis of sepsis and bacteria detected by culture, a
statistical significance between mortality and Salmonella,
Shigella, Staphylococcus aureus, or Pseudomonas aeruginosa
infections were found (Table 2).
The Student’s t-test was used to compare fatal and
nonfatal cases of sepsis. Here, we observed a statistically
significant difference in neutrophil percentage, blood urea
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Table 1. Demographic patterns of age and length of hospital stay and general demographic patterns of patients diagnosed with septicemia
in terms of sex and clinical distribution according to mortality.
Mean ± standard deviation

Sex (mean ± standard deviation)
(n = 86)
Male (n = 41)

Female (n = 45)

P < 0.05

Age

75.25 ± 16.51

70.59 ± 18.97

79.51 ± 12.68

0.013

H-LOS

27.54 ± 16.5

28.90 ± 33.29

26.31 ± 29.78

0.704

Total number of cases

P < 0.05

Mortality
Mortality cases (n = 41)

Discharged cases (n = 45)

Total number of cases (n = 86)

Male

29 (53.7%)

12 (29.3%)

41

Female

25 (46.3%)

20 (60.6%)

45

GICU

52

24

Other clinics

1

9

86

0.153
0.018

Length of hospital stay [(H-LOS) (days)], age (years); GICU: general intensive care unit. Other clinics include centres for palliative care,
chest diseases, internal medicine, coroner intensive care, orthopedia, and traumatology.

nitrogen value (BUN), creatine, INR, and active partial
thromboplastin time (APTT) between fatal and nonfatal
cases (Table 3).
Using logistic regression analysis performed after
advanced statistical analysis, which followed the univariate
analysis, the presence of P. aeruginosa appeared statistically
significant among the cases diagnosed with sepsis and was
observed to be the most important factor contributing to
mortality (Table 4).
Separately, the results of the univariate analysis showed
that the percentage of neutrophils was different between
the patients who died and those who survived, although
the values were not located within the confidence limits
(Table 4).
4. Discussion
The term ‘zoonos’ is used to discuss diseases that concern
both humans and animals. Transition to humans can be
from either domestic or wild animals. Along these lines,
many animals and their products can serve as reservoirs
for zoonotic pathogens [13].
On the other hand, a ‘nosocomial infection’ is when
hospital-acquired or health-related infections occur in
patients under or receiving medical care. These infections,
which are common worldwide, constitute a major medical
problem in both developed and developing countries.
Nosocomial infections are reported at rates of 7% in
developed countries and 10% in developing countries [14].
Bacterial, viral, and fungal pathogens can be responsible
for nosocomial infections. Common routes of infection
in this context include central catheterisation, urinary
catheterisation, surgical area infections, and ventilatorrelated pneumonia [14]. As these infections occur in

patients under hospitalisation, they may also cause longterm disability and economic burden [15].
Nosocomial infections affect a large number of patients
worldwide. According to Jones et al., P. aeruginosa, K.
pneumoniae, Acinetobacter spp., and Escherichia coli have
developed as notable nosocomial pathogens due to their
multidrug resistance. This may be related to the outcome
of P. aeruginosa as the most impactful pathogen in our
study. Moreover, among the isolates tested by Jones et
al., P. aeruginosa appeared as the bacteria most resistant
to antibiotics [16]. In 2019, Scott et al. reported that P.
aeruginosa strains obtained in a veterinary department,
which displayed high levels of resistance to polymyxin,
had a significantly similar genetic status between some
human and animal isolates. The authors also proposed
that continuous surveillance is needed in both animals and
humans [17]. Flammer reported that many enteric bacteria
spread primarily through the fecal–oral route but that
the transfer of enteric bacteria can be effectively reduced
by proper hygiene, animal husbandry, and disinfection
[18]. Pittet et al. also documented the effectiveness of
simple precautions such as hand washing, which is very
easy and important to do [19]. In research conducted by
Hall et al. and Brand et al., it was stated that zoonotic
bacteria affecting morbidity and mortality were observed
among people, including P. aeruginosa [20,21]. Because
P. aeruginosa transmission can occur from birds taken
from pet shops whose ancestors were tropical sea birds,
we believe that consideration of this point is important. P.
aeruginosa is a very common pathogen that can be found
in almost 20% of nosocomial infections in the blood
circulation of all Gram-negative bacteria [22]. In addition
to being widespread, this pathogen has been shown
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Table 2. Results of the bacterial species isolated from cultures; white blood cell counts (low ≤ 4000 109
cells/L and leukocytosis ≥ 12,000 109 cells/L) were evaluated for chi-squared mortality.
Mortality (+)

Mortality (−)

P < 0.05

Age (years)

73.17 ± 17.97

78.77 ± 13.23

0.128

Length of hospital stay (days)

28.59± 31.39

25.78 ± 31.66

0.69

P. aeruginosa (+)

22

5

0.012*

WBC ≤ 4000 or WBC ≥ 12,000 10 cells/L

64 (81%)

15 (19%)

0.396

Klebsiella spp.

3

4

0.275

Klebsiella pneumoniae

14

4

0.139

Acinetobacter spp.

8

3

0.436

Micrococus luteus

1

0

0.432

Burkholderia cepacia

0

1

0.198

Acinetobacter baumanii

4

4

0.460

Difteroid bacil

3

2

0.922

Salmonella

9

0

0.013*

Shigella

8

0

0.022*

Serratia marcescens

0

1

0.198

Escherichia coli

12

5

0.420

Proteus mirabilis

2

1

0.867

Meticillin-sensitive Staphylococcus aereus

0

1

0.198

Coagulase (−) Staphylococcus aereus

5

1

0.401

Staphylococcus haemolyticus

1

0

0.379

Coagulase (+) Staphylococcus aereus

0

3

0.05*

Staphylococcus hominis

1

2

0.554

Staphylococcus epidermis

3

0

0.291

Streptococcus spp.

0

1

1.000

Enterococcus spp.

0

1

1.000

Pseudomonas spp.

4

1

0.646

Candida albicans

7

2

0.473

Candida spp.

11

4

0.323

Enterobacter cloaca

0

1

1.000

Proteus vulgaris

1

0

1.000

Proteus spp.

5

3

1.000

Klebsiella oxytoca

0

1

0.379

9

to promote adverse outcomes with high mortality and
morbidity rates in patients. Therefore, significant efforts
by researchers to identify survival-related factors and
treatment options are ongoing. In this clinical study, we
found that P. aeruginosa was a contributing factor in 40.7%
of deaths among patients with sepsis, which is consistent
with the literature. In the literature, patient mortality
following P. aeruginosa infection has been associated with
both microbial and host-related factors [23]. Bacterial
infections that cause mortality have especially high internal
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virulence characteristics. Balibar et al. showed that Gramnegative bacteria have multiple mechanisms of resistance
against antibacterial drugs, and this is attributed to their
cell envelope structure and to the fact that molecules that
pass through this envelope structure are often ejected by
multiple drug-flow pumps. For these reasons, Balibar et
al. preferred using P. aeruginosa in their in vitro studies
[24]. In contrast, Wu et al. [25] reported that P. aeruginosa
caused cytotoxicity in many cell types and through
production of 1 of 2 type III secreted exotoxins: ExoS or
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Table 3: Univariate analysis results of continuous independent variables by Student’s t-test.
Total number of patients (n = 86)

Mortality (+) (n = 54)

Mortality (−) (n = 32)

P-value

Age (years)

73.17 ± 17.97

78.77 ± 13.23

0.128

Length of hospital stay (days)

28.59 ± 31.39

25.78 ± 31.66

0.692

Fever

38.15 ± 0.69

38.06 ± 0.78

0.597

Pulse

96.72 ± 8.26

98.39 ± 6.67

0.304

Respiratory rate

23.96 ± 19.78

20.48 ± 2.74

0.319

Leukocyte count

16647 ± 15368

17889 ± 11207

0.801

Percentage of neutrophils

84.4 ± 7.64

74.4 ± 10.81

0.015*

Hgb

9.69 ±2.07

9.81 ± 1.70

0.809

CRP

53.4 ± 98.5

48.5 ± 64.9

0.826

Ca

7.85 ± 0.79

8.12 ± 0.91

0.227

Albumin

2.29 ± 0.71

2.46 ± 0.50

0.349

APTT

48.35 ± 22.35

39.9 ± 8.35

0.037*

PT

23.06 ± 15.68

22.51 ± 29.4

0.926

INR

2.03 ± 1.69

1.26 ± 0.199

0.007*

BUN

56.8 ± 40.35

38.8 ± 29.82

0.044*

Creatinine

1.56 ± 0.89

1.10 ± 0.91

0.041*

CRP: C-reactive protein; Ca: calcium; APTT: active partial thromboplastin time; PT: prothrombin time;
INR: international normalised ratio; Hgb: hemoglobin.
Table 4. Evaluation of the significant results in univariate analysis resubjected to further statistical analysis by multiple linear and binary
logistic regression.
Adjusted odds ratio (95% CI)/
adjusted mean difference (95% CI), P-value
95% CI for EXP (B)

Total number of patients (n = 86)

Mortality (+)
(n = 54)

Mortality (−)
(n = 32)

P

P. aeruginosa (+) vs. (−)

22 (40.7%) vs.
32 (59.3%)

5 (11.2%) vs.
28 (84.8%)

0.012

3.54* (1.09–11.454)

0.03*

White blood cell number (WBC) < 4000 vs. 38 (74.5%) vs.
WBC > 12,000 (+/−) 109 cells/L
13 (25.5%)

24 (82.8%)
vs. 5 (17.2%)

0.396

0.365 (0.11–1.23)

0.103

Percentage of neutrophils

74.4 ± 10.81

0.015

0.404 (0.08–0.04)

0.002*

84.4 ± 7.64

ExoU [26,27]. When we examined the multiple resistance
mechanisms of this bacterium, the low permeability of the
outer membrane was found to result from the structural
presence of β-lactamases, the efficacy of outflow pumps,
and the ability to express resistance genes (e.g., following
genetic gain for β-lactamases). Notably, these mechanisms
are often present simultaneously, which lead to the highly
resistant phenotypes found in both humans and animals
[26,27]. Therefore, susceptibility testing is especially
important for P. aeruginosa in clinical practice. We believe
that detection of resistance to antibacterial agents in this
study is very important in terms of the isolates concomitant

to both human and animal origin. As we emphasise in
Tables 3 and 4, when we look at what affected mortality in
our study, some markers that initially were hypothesised
as having predictive properties were not found to be
significant in other studies, univariate analysis, or the final
logistic regression analysis. These results maybe dependent
on the limited number of cases and may also depend on the
limited number of studies available in this area. Among the
variables that were mentioned above, urea, creatinine, CRP,
hemoglobin, partial thromboplastin time, prothrombin
time, INR, fever, respiratory rate, and heart rate were
not found to be significant variables. Instead, the most
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significant factor influencing mortality was P. aeruginosa
infection. We believe that the presence of P. aeruginosa
appeared as a significant risk factor for mortality [3.53
(1087–11.54); P < 0.036)] (Table 4) in this study probably
because of the organism’s multiple resistance mechanisms
and high virulence characteristics. Host factors correlated
with poor outcomes include neutropenia, prolonged
bacteremia duration, pneumonic source, shock, renal
failure, and metastatic foci of infection [28,29]. On the
other hand, host factors associated with higher rates
of mortality and morbidity include other important
medical problems and neutropenia, long-term exposure
to bacteremia, pneumonic infection focus, renal failure
shock, and metastatic foci of infection [28,29]. In this
study, the percentage of neutrophils was found to be
significant following a univariate analysis, which was not
in agreement with outcomes reported in the literature.
Similarly, the percentage of neutrophils was found to be a
significant risk factor for P. aeruginosa-induced mortality,
although it was not statistically within the confidence
limits using multiple linear regression (84.4% ± 7.64%
and 74.4% ± 10.81%; P = 0.015) [AOR: 0.404 (0.08–0.04);
P = 0.002)] (Table 4).
On the subject of BUN, Al-Aloul et al. reported 8 cases
of acute renal failure (ARF) following the administration
of intravenous aminoglycosides for the treatment of
pulmonary exacerbations with an epidemic highly
resistant P. aeruginosa strain in adult patients with cystic
fibrosis [30]. In our present study, BUN and creatinine
levels were not recorded as statistically significant. Bilgili
et al. noted that although the most common cause of
ARF in critically ill patients is sepsis, limited knowledge
exists about sepsis-related ARF. The authors stated that
medications that have long been successful in animals
for the treatment of ARF have unfortunately not been
similarly effective in most people experiencing sepsis
and sepsis shock in intensive care units. They further
suggested that sepsis is a common cause of death and that
this necessitated new investigations into the diagnosis and
treatment of sepsis-related ARF [31]. On the other hand,
Souza et al. [32] stated that exposure to P. aeruginosa may
cause septic shock, especially in patients with chronic
renal failure. Therefore, we believe that the creatinine
level, which is important in renal function, is higher in
cases that experience mortality and that abnormal renal
function may have the potential to progress to failure more
rapidly in cases where this pathogen is present. Pradhan
et al. emphasised that CRP is useful in identifying patients
with sepsis diagnosed with SIRS. In addition, they stated
that CRP could be a very useful marker in resourcerestricted areas where sepsis specialists are not available
and especially in places where data on procalcitonin or
interleukins are not accessible [33]. In our study, although
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there was no difference between mortal and nonmortal
cases diagnosed with sepsis, this does not minimise the
fact that CRP may be beneficial in the diagnosis of sepsis,
although it is not predictive for all aspects of the condition.
According to the results of a study on calves published
in 2006 considering the use of APTT and prothrombin
time, FDPs, and PLT for diagnosing sepsis, the animals
with questionable septic shock demonstrated a spectrum
of hemostatic dysfunction [34]. In our study, these
markers were not statistically and significantly effective
in making a diagnosis of sepsis. According to the results
of Quinten et al. in 2015, sepsis lacks a reliable and easily
obtainable way to measure disease activity. Along these
lines, to discern the treatment effect of sepsis patients, the
authors stated that trends showing an increase in oxygen
saturation and blood pressure and a decrease in heart
rate, respiratory rate, and body temperature could be
considered positive responses. Based on the results of that
study, it is underlined that the use of vitals data should
be further considered. Additionally, the authors stressed
that it is an advantage that these data can be collected
easily, inexpensively, and noninvasively, alongside being
able to indicate significant changes where they appear
[35]. In our study, there was no statistical significance
between mortal and nonmortal sepsis cases in terms
of body temperature, heart rate, and respiratory rate.
For this reason, we believe that vitals data may be more
suitable for conducting follow-up rather than predicting
mortality from sepsis. In 2001, Dennesen et al. found that
tracheal colonisation by resistant pathogens such as P.
aeruginosa emerged in the second week of treatment [36].
Additionally, Bisbe et al. reported that following
univariate and multivariate analyses of the factors
affecting prognosis [37] among 133 consecutive sequences
in P. aeruginosa bacteremia, P. aeruginosa was the most
common cause of negative nosocomial bacteremia
(25.6%). In the present study, when we examined the
average hospitalisation period of the patients who died,
we noted that they stayed in the hospital for nearly 1
month (28.59 ± 31.39 days). In addition, Bisbe et al. [37],
in their consecutive analysis of 133 cases, reported direct
(45%) or indirect (5%) mortality rates in association
with infection and noted that approximately half of the
recorded deaths occurred during the first 2 days following
the detection of bacteremia [37]. Approximately half of
these cases were patients hospitalised in intensive care
units or in renal or bone marrow transplantation units
[37]. As emphasised in the literature, we believe that
this pathogen should be proactively addressed where
possible, especially in intensive care units because of the
potential for rapid onset and the high risk of mortality.
In our study, we found a 3.5-fold increase in mortality
and observed that 98.2% of sepsis-related deaths were
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caused by P. aeruginosa. However, other bacterial or viral
pathogens may also cause a similar risk in the future.
Thus, the possibility of zoonotic transmission must
always be considered, especially when facing epidemic
tragedies.
In conclusion, the risk of passing zoonotic diseases
to people is increasing, and this can lead to very

tragic consequences worldwide. P. aeruginosa with
zoonotic colonisation and transition features can lead
to an infection that can also cause sepsis and mortality,
especially in patients in intensive care. Due to the
potential of zoonotic transmission, it should always be
kept in mind as it is still a very important zoonotic risk
factor affecting patient care outcomes.
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